Not Tagged
Not Tagged
['sclc', 'nsclc']
today, 6/3, hall d1, 1:12pm cdt:
#fdaoncology presents outcomes of 1st-line immune checkpoint inhibitors with/without chemotherapy according to kras mutational status &amp; pd-l1 expression in patients with advanced nsclc. #asco22 abstract 9001 
FDA Oncology Center of Excellence expedites medical product development to improve the lives of people with cancer. Privacy Policy - https://t.co/8c0o687SdC